Skip to main content
TipRanks
Go Ultimate75% OFF

ImmunityBio (IBRX) Q3 2021 Earnings Report

2,637 Followers

IBRX Q3 2021 EPS Results

Actual EPS
-$0.22
Consensus EPS
-$0.20
Beat/Miss
Missed by -$0.02
One Year Ago EPS
-$0.20

IBRX Q3 2021 Revenue Results

Actual Revenue
$66.00K
Expected Revenue
$25.00K
Beat/Miss
Beat by +$41.00K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2021
Date
11/12/2021
Time
TBA
Conference Call
Friday, November 12, 2021
IBRX Upcoming Earnings

ImmunityBio's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q3 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

IBRX Earnings History

IBRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)-0.14--0.06――
Nov 09, 20262026 (Q3)-0.07-0.18-0.07-157.14% (-0.11)
Aug 04, 20262026 (Q2)-0.08-0.22-0.1-120.00% (-0.12)
May 07, 20262026 (Q1)-0.07-0.62-0.15-313.33% (-0.47)
Mar 03, 20262025 (Q4)-0.08-0.06-0.0933.33% (+0.03)
Nov 04, 20252025 (Q3)-0.11-0.07-0.1450.00% (+0.07)
Aug 05, 20252025 (Q2)-0.11-0.10-0.250.00% (+0.10)
May 12, 20252025 (Q1)-0.13-0.15-0.225.00% (+0.05)
Mar 03, 20252024 (Q4)-0.20-0.09-0.3675.00% (+0.27)
Nov 12, 20242024 (Q3)-0.18-0.14-0.1926.32% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed